93 results match your criteria: "The Rane Center[Affiliation]"
J Vasc Surg Venous Lymphat Disord
January 2025
The RANE Center for Venous & Lymphatic Diseases, Jackson, MS.
J Vasc Surg Venous Lymphat Disord
January 2025
The RANE Center for Venous & Lymphatic Diseases, St. Dominic Hospital, Jackson, MS. Electronic address:
Objectives: Phlebolymphedema, the most common cause of secondary lymphedema in Western societies, seldom gets the attention it deserves. Diagnosis is often missed and when evaluated is through lymphoscintigraphy (LSG) which is cumbersome. This study aims to assess the role of computed tomography (CT) scanning in the diagnosis of phlebolymphedema of the lower extremities by comparing CT characteristics with the International Society of Lymphology (ISL) grading system and LSG.
View Article and Find Full Text PDFJ Vasc Surg Venous Lymphat Disord
January 2025
Department of Vascular Surgery, Leiden University Medical Center, Leiden, the Netherlands. Electronic address:
Background: Nutcracker syndrome (NCS) describes the symptomatic compression of the left renal vein between the aorta and superior mesenteric artery. Whereas asymptomatic compression is a common radiological finding, patients with NCS can report a range of symptoms. There are no specific diagnostic criteria and interventions include a range of open surgical and endovascular procedures.
View Article and Find Full Text PDFJ Vasc Surg Venous Lymphat Disord
July 2024
The RANE Center for Venous & Lymphatic Diseases, St. Dominic Hospital, Jackson, MS.
JVS Vasc Sci
March 2024
California Medical Innovations Institute, San Diego, CA.
J Vasc Surg Venous Lymphat Disord
September 2024
The RANE Center for Venous & Lymphatic Diseases, St. Dominic Hospital, Jackson, MS. Electronic address:
Objective: Venous stenting has become the first line of treatment for patients with symptomatic chronic iliofemoral venous obstruction (CIVO) in whom conservative therapy has failed. Intravascular ultrasound (IVUS) interrogation with the use of normal minimal luminal diameters or areas has become the standard to confirm the diagnosis and determine the adequacy of stenting. However, the aspect ratio (ratio between the maximal and minimal luminal diameters) has also been put forth as a possible metric for determining stent adequacy.
View Article and Find Full Text PDFJ Vasc Surg Venous Lymphat Disord
July 2024
The RANE Center for Venous & Lymphatic Diseases, Jackson, MS.
Background: Column interruption duration (CID) is a noninvasive surrogate for venous refill time (VFT), a parameter used in ambulatory venous pressure measurement. CID is more accurate than invasive VFT measurement because it avoids errors involved with indirect access of the deep system through the dorsal foot vein. The aim of this retrospective single center study is to analyze the clinical usefulness of CID in assessment of chronic venous disease (CVD).
View Article and Find Full Text PDFFront Bioeng Biotechnol
November 2023
California Medical Innovations Institute, San Diego, CA, United States.
J Vasc Surg Cases Innov Tech
December 2023
The RANE Center for Venous & Lymphatic Diseases, Jackson, MS.
Treatment of venous aneurysms involving the iliac and femoral veins has generally been an open surgical approach, with a few case reports noting use of an endovascular approach. We report three cases: (1) a patient with an iliocaval occlusion involving an occluded TrapEase filter who presented with a large left external iliac vein aneurysm; (2) a patient with a left common femoral vein aneurysm; and (3) a patient with left profunda femoris vein aneurysms with associated pulmonary embolism. All three patients were successfully managed with the use of appropriately sized bare metal woven stents (Wallstents; Boston Scientific).
View Article and Find Full Text PDFJ Vasc Surg Venous Lymphat Disord
January 2024
The RANE Center for Venous & Lymphatic Diseases, St. Dominic Hospital, Jackson, MS.
Objective: Phlebolymphedema has been noted to be one of the most common causes of lymphedema in the lower extremity in western societies. Although complex decongestive therapy (CDT) represents the mainstay of lymphedema treatment, its role for phlebolymphedema arising from chronic iliofemoral venous obstruction (CIVO) merits further exploration. We evaluated this through the use of a protocol of CDT first for limbs with CEAP (clinical, etiologic, anatomic, pathophysiologic) clinical C3 disease and stent correction of obstruction before CDT for those with more advanced disease (CEAP C4-C6).
View Article and Find Full Text PDFJ Vasc Surg Venous Lymphat Disord
November 2023
The RANE Center for Venous & Lymphatic Diseases, St Dominic Hospital, Jackson, MS.
Objective: Recent studies have emphasized the important role lymphatics play in the drainage of interstitial fluid and edema prevention. Although the infrainguinal lymphatics have been studied in some depth, with patterns of pathology identified, such data above the groin are sparse, especially for patients with phlebolymphedema. The present study attempts to evaluate the status of lymphatic flow above the inguinal ligament in patients presenting with edema and undergoing stenting for symptomatic chronic iliofemoral venous obstruction (CIVO).
View Article and Find Full Text PDFSci Rep
June 2023
California Medical Innovation Institute, San Diego, CA, USA.
J Vasc Surg Venous Lymphat Disord
May 2023
The RANE Center for Venous and Lymphatic Diseases, Jackson, MS.
J Vasc Surg Venous Lymphat Disord
May 2023
The RANE Center for Venous and Lymphatic Diseases, Jackson, MS.
J Pers Med
February 2023
The RANE Center for Venous and Lymphatic Diseases, Suite 401, 971 Lakeland Drive, Jackson, MS 39216, USA.
Unlike arterial disease, chronic venous disease (CVD) is rarely life-threatening or limb-threatening. However, it can impose substantial morbidity on patients by influencing their lifestyle and quality of life (QoL). The aim of this nonsystematic narrative review is to provide an overview of the most recent information on the management of CVD and specifically, iliofemoral venous stenting in the context of personalized considerations for specific patient populations.
View Article and Find Full Text PDFJ Vasc Surg Venous Lymphat Disord
March 2023
The RANE Center for Venous and Lymphatic Diseases, Jackson, MS.
Ann Vasc Surg
May 2023
The Rane Center for Venous and Lymphatic Diseases, Jackson, MS. Electronic address:
J Vasc Surg Venous Lymphat Disord
May 2023
The RANE Center for Venous and Lymphatic Diseases, Jackson, MS.
Objective: The goal of endovenous stenting is to relieve venous obstruction and reduce peripheral venous hypertension by using large caliber venous stents in the presence of adequate venous inflow and outflow for the stented conduit. The aim of this report is to describe the technical reasons and outcomes for reinterventions in a subset of patients who had a history of iliac vein stenting and were now referred to us at a specialty venous clinic for further care.
Methods: From January 2016 to December 2021, records of all patients who were referred to us with a history of iliac vein stenting performed at an outside facility and who had a reoperation performed at our center were retrospectively analyzed.
J Vasc Surg Venous Lymphat Disord
January 2023
The RANE Center for Venous and Lymphatic Diseases, Jackson, MS.
J Vasc Surg Venous Lymphat Disord
March 2023
The RANE Center for Venous & Lymphatic Diseases, Jackson, MS.
Background: Calf pump failure (CPF) is a common concept in chronic venous disease. Dorsal vein pressures were originally used to define the pathophysiology. More recently, an abnormal ejection fraction (EF) and residual volume fraction (RVF) with air plethysmography (APG) have been substituted for its diagnosis.
View Article and Find Full Text PDFJ Vasc Surg Venous Lymphat Disord
March 2023
The RANE Center for Venous and Lymphatic Diseases, Jackson, MS.
Background: The Reynolds number (R) is a dimensionless parameter that describes fluid flow mechanics. Veins are compliant and collapsible vascular conduits that can accommodate large volume changes in response to small pressure changes. However, only sparse information is available about flow parameters such as the R in the venous system.
View Article and Find Full Text PDFJ Vasc Surg Venous Lymphat Disord
March 2023
The RANE Center for Venous and Lymphatic Diseases,Jackson, MS.
Background: We have recently demonstrated in a large patient cohort that the prevalence and severity of reflux will improve in most limbs after stenting and that most limbs will not develop new-onset reflux. In the present report, we have focused on the long-term clinical outcomes associated with untreated reflux in the same patient cohort who had undergone iliofemoral venous stenting without correction of residual reflux.
Methods: The clinical outcomes data from 1379 limbs treated with only iliac vein stenting without correction of superficial or deep reflux from 1997 to 2018 were analyzed (23-year follow-up period).
J Vasc Surg Cases Innov Tech
December 2022
The RANE Center for Venous & Lymphatic Diseases, St. Dominic Hospital, Jackson, MS.
Although clinical improvement after stenting for symptomatic iliofemoral venous obstruction has been demonstrated in multiple large studies, a small proportion of patients will experience persistent quality of life-impairing symptoms. Swelling in such a setting represents the concomitant presence of lymphedema and will respond to treatment directed at the lymphedema. In contrast, persistent pain likely arises from venous hypertension in the lower leg, leading to the development of chronic compartment syndrome.
View Article and Find Full Text PDF